{"id":26257,"date":"2020-08-04T09:58:00","date_gmt":"2020-08-04T09:58:00","guid":{"rendered":"http:\/\/978b32bb036c18cd8050fcfb2901363e"},"modified":"2024-11-03T15:16:21","modified_gmt":"2024-11-03T15:16:21","slug":"tp53-allelic-state-is-critical-in-myelodysplastic-syndromes","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/tp53-allelic-state-is-critical-in-myelodysplastic-syndromes\/","title":{"rendered":"TP53 Allelic State is Critical in Myelodysplastic Syndromes"},"content":{"rendered":"<p>A study performed among 3,324\u2009patients with myelodysplastic syndromes (MDS) with analysis of <em>TP53<\/em>&nbsp;mutations and allelic imbalances shows that consideration of&nbsp;<em>TP53<\/em>&nbsp;allelic state is critical for diagnostic and prognostic precision in MDS, as well as in future correlative studies of treatment response. The findings are published on 3 August in the <em>Nature Medicine<\/em> by a group of international researchers. Seishi Ogawa of the Department of Pathology and Tumor Biology, Kyoto University in Kyoto, Japan and Elli Papaemmanuil of the Computational Oncology Service, Department of Epidemiology &amp; Biostatistics, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA jointly supervised this work.<\/p>\n<p>The authors wrote in the study background that <em>TP53<\/em> is the most frequently mutated gene in cancer. In patients with MDS,&nbsp;<em>TP53<\/em>&nbsp;mutations are associated with high-risk disease, rapid transformation to acute myeloid leukaemia, resistance to conventional therapies&nbsp;and dismal outcomes.<\/p>\n<p>Consistent with the tumour suppressive role of&nbsp;<em>TP53<\/em>, patients harbour both mono- and biallelic mutations. However, the biological and clinical implications of&nbsp;<em>TP53<\/em>&nbsp;allelic state have not been fully investigated in MDS.<\/p>\n<p>The study team delineated two subsets of patients with distinct phenotypes and outcomes. One-third of&nbsp;<em>TP53<\/em>-mutated patients had monoallelic mutations whereas two-thirds had multiple hits (multi-hit) consistent with biallelic targeting.<\/p>\n<p>Established associations with complex karyotype, few co-occurring mutations, high-risk presentation and poor outcomes were specific to multi-hit patients only.&nbsp;<em>TP53<\/em>&nbsp;multi-hit state predicted risk of death and leukemic transformation independently of the Revised International Prognostic Scoring System.<\/p>\n<p>Monoallelic patients did not differ from&nbsp;<em>TP53<\/em>&nbsp;wild-type patients in outcomes and response to therapy.<\/p>\n<p>The authors concluded that their study shows that <em>TP53<\/em>&nbsp;allelic state is critical for diagnostic and prognostic precision in MDS.<\/p>\n<p>Clinical, copy number and mutation data from this work are available <a href=\"https:\/\/github.com\/papaemmelab\/MDS-TP53-state\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"external-link\">here<\/a>.&nbsp;Databases used in the study are gnomAD, COSMIC, cBioPortal for Cancer Genomics, OncoKB Precision Oncology Knowledge Base, ClinVar and the IARC TP53 Database.<\/p>\n<p>This work was supported in part by grants from the Celgene Corporation through the MDS Foundation. It was also supported by multiple grants to individual investigators.<\/p>\n<p><strong>Reference<\/strong><\/p>\n<p>Bernard E, Nannya Y, Hasserjian RP, <em>et al.<\/em> <a href=\"https:\/\/www.nature.com\/articles\/s41591-020-1008-z\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"external-link\">Implications of&nbsp;<em>TP53<\/em>&nbsp;allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes<\/a>. <em>Nature Medicine;<\/em> Published online 3 August 2020. DOI: https:\/\/doi.org\/10.1038\/s41591-020-1008-z<\/p>\n<p><a href=\"http:\/\/www.esmo.org\/oncology-news\/tp53-allelic-state-is-critical-in-myelodysplastic-syndromes\">Source<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>A study performed among 3,324\u2009patients with myelodysplastic syndromes (MDS) with analysis of TP53&nbsp;mutations and allelic imbalances shows that consideration of&nbsp;TP53&nbsp;allelic state is critical for diagnostic and prognostic precision in MDS, as well as in future correlative studies of treatment response. The findings are published on 3 August in the Nature Medicine by a group of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5137],"tags":[],"class_list":["post-26257","post","type-post","status-publish","format-standard","hentry","category-world-news"],"_links":{"self":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/comments?post=26257"}],"version-history":[{"count":1,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26257\/revisions"}],"predecessor-version":[{"id":45600,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26257\/revisions\/45600"}],"wp:attachment":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media?parent=26257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/categories?post=26257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/tags?post=26257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}